← FDA Drug Approvals (Drugs@FDA)

METHYLDOPATE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1991-11-22

Drug application

FDA Application #

ANDA072974

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLDOPATE HYDROCHLORIDE

Generic name

Methyldopate Hydrochloride

Active ingredients

METHYLDOPATE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

1991-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown